protoporphyrin IX

5'-aminolevulinate synthase 2 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31076252 Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria. 2019 Nov 1
2 31395332 Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. 2019 Nov 4
3 25615817 X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria. 2016 Jan 1
4 25179834 In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability. 2015 Jan 1
5 26300302 Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release. 2015 Sep 15 1
6 24509859 Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria. 2014 Mar 14 1
7 24718052 Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death. 2014 4
8 23263862 Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP). 2013 Apr 1 1
9 24135682 Annular elastolytic giant cell granuloma associated to late-onset X-linked dominant protoporphyria. 2013 1
10 21627978 Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria. 2011 Jul 1
11 20850938 [Inheritance in erythropoietic protoporphyria]. 2010 Oct 1
12 10522552 Cell biology of heme. 1999 Oct 1